Immorta Bio
Immorta Bio, Inc.
Immorta Bio is a longevity biotech company developing stem-cell and senescent-cell therapeutics to reverse biological aging and unlock regenerative healthspan
immortabio.com · Miami Beach, FL
Funding event
The round itself, as filedInferred stagePre-seed
Sold of offered$613K of $5.0M
Filed2026-10-16
Days since filing28
- Exemption claimed
- Rule 506(c)
- First-ever Form D
- No
- Date of first sale
- 2024-11-05
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Boris ReznikExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedFlagged$613K of $5.0M sold24.2 months since first sale
Prior raiseNot flaggedRaised $613K against a prior $450K$450K prior raise, filed 2026-01-08
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-10-180
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.